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Abstract
Background: Peripheral artery disease (PAD) affects over 236 million people worldwide, and exercise interventions are
commonly used to alleviate symptoms of this condition. However, no previous systematic review has evaluated the effects of
mobile health (mHealth)–based exercise interventions for patients with PAD.
Objective: This study aimed to assess the effect of mHealth-based exercise interventions on walking performance, functional
status, and quality of life in patients with PAD.
Methods: A systematic review and meta-analysis were conducted. We searched in seven databases to identify randomized
controlled trials of patients with PAD published in English up to December 4, 2020. Studies were included if patients participated
in mHealth-based exercise interventions and were assessed for walking performance. We analyzed pooled effect size on walking
performance, functional status, and quality of life based on the standardized mean differences between groups.
Results: A total of seven studies were selected for the systematic review, and six studies were included in the meta-analysis.
The duration of interventions in the included studies was 12 to 48 weeks. In the pooled analysis, when compared with the control
groups, the mHealth-based exercise intervention groups were associated with significant improvements in pain-free walking
(95% CI 0.13-0.88), maximal walking (95% CI 0.03-0.87), 6-minute walk test (6MWT) distance (95% CI 0.59-1.24), and walking
distance (95% CI 0.02-0.49). However, benefits of the interventions on walking speed, stair-climbing ability, and quality of life
were not observed.
Conclusions: mHealth-based exercise interventions for patients with PAD were beneficial for improving pain-free walking,
maximal walking, and 6MWT distance. We found that exercise interventions using mHealth are an important strategy for improving
the exercise effectiveness and adherence rate of patients with PAD. Future studies should consider the use of various and suitable
functions of mHealth that can increase the adherence rates and improve the effectiveness of exercise.
(JMIR Mhealth Uhealth 2021;9(2):e24080) doi: 10.2196/24080
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Peripheral artery disease (PAD) is a major cardiovascular
disease characterized by limitations to arterial blood flow in the
lower extremities (commonly due to atherosclerosis) and
ischemia that can induce walking impairments [1,2]. PAD
affects the lower extremities more commonly than the upper
extremities and may present as intermittent claudication, atypical
leg symptoms, critical limb ischemia, and functional
impairments [1,3]. Regardless of the presence of symptoms,
however, patients with PAD are at a significant risk of
cardiovascular morbidity and mortality [2].
PAD is estimated to affect over 236 million people worldwide,
and the prevalence increases steeply with age [4,5]. Given the
increases in the pace of population aging in many countries,
PAD prevalence can be expected to increase further [5].
Structured exercise programs are an important therapy for
patients with PAD and can be administered in the form of
supervised exercise therapy (SET) or structured community- or
home-based exercise therapy (HBET) [1,3]. SET is directly
supervised by health care providers in hospital or outpatient
facilities, and HBET is self-exercise under the guidance of health
care providers in a personal setting [3]. Structured exercise
programs have been found to improve walking performance,
functional status, and health-related quality of life (QoL) and
also to prevent functional decline and mobility loss [3,6].
However, these benefits are most effective when patients
actively and comprehensively participate in the interventions
[7,8].
According to previous systematic reviews, 30.3% of the patients
who participate in exercise interventions show incomplete
adherence, mainly due to a lack of motivation, health reasons,
patient choice, and a lack of results [6,9]. Adherence to exercise
interventions is directly related to the likelihood of a participant
changing or maintaining his/her health behaviors [10].
Therefore, it is necessary to find strategies for improving
adherence rates to promote behavior changes.
Data-driven approaches involving the use of mobile devices
such as mobile phones and wireless devices in exercise
interventions have been shown to be effective for improving
health outcomes [10,11]. The mobile health (mHealth) approach
facilitates extensive supervision and the monitoring of patients
without requiring an increase in human resources [12]. In
particular, the provision of interventions based on mHealth
technologies allows health care providers to provide real-time
advice related to therapy and to monitor symptoms and problems
without any restrictions on location [13,14]. Thus, well-designed
mHealth-based interventions can be used to provide health
education and promote behavior changes and have the potential
to improve exercise adherence [10,12].
Previous systematic reviews on patients with PAD have mainly
focused on the effects of SET, HBET, and endovascular
revascularization [15-20]. In addition, some studies have sought
to identify more efficient methods of PAD screening and the
factors that influence participation in physical activity [21,22].
However, existing reviews have not evaluated the effects of
mHealth-based exercise interventions on patients with PAD.
To guide the development of future exercise interventions, there
is a need for evidence regarding mHealth-based exercise
interventions. Thus, in this study, we conducted a systematic
review and meta-analysis with a particular focus on the effects
of mHealth-based exercise interventions on walking
performance, functional status, and QoL in patients with PAD.
In addition, adherence rates in exercise interventions and the
applied mHealth functions were investigated.
Methods
The systematic review and meta-analysis were performed in
accordance with the Preferred Reporting Items for Systematic
Reviews and Meta-Analyses (PRISMA) guidelines (Multimedia
Appendix 1). The protocol for this study is registered with
PROSPERO (registration number: CRD 42020191744).
Systematic Search Strategy
The systematic literature search was designed to identify
randomized controlled trials (RCTs) of patients with PAD that
were published in the English language in peer-reviewed
journals up to December 4, 2020. We performed searches in
the following seven databases: PubMed, CINAHL, Cochrane
CENTRAL, EMBASE, IEEE Xplore Digital Library, Web of
Science, and Scopus. We used a combination of keywords and
controlled vocabulary terms such as MeSH and Emtree subject
headings using Boolean operators, and this was followed by
consultation with a professional medical librarian (Multimedia
Appendix 2).
Inclusion and Exclusion Criteria
Studies that met the following inclusion criteria were selected:
(1) included adult patients with PAD; (2) conducted
mHealth-based exercise interventions, such as with mobile
phones, wearable devices, and activity trackers; (3) reported
walking performance comparing an mHealth intervention group
with a control group; and (4) used an RCT design. We excluded
studies with the following criteria: (1) not published in English;
and (2) not an original article.
Study Selection
Based on the search strategy, studies were extracted from the
seven databases and duplicates were removed. Two authors
(MK and EK) independently screened the titles and abstracts
of the remaining studies to determine their eligibility for the
study based on the inclusion and exclusion criteria. The full
texts of the selected studies were subsequently assessed and the
final studies to be included in the analysis were selected.
Thereafter, we manually searched the reference lists of all
included studies for additional relevant studies. In instances
where there were disagreements regarding decisions, a third
author (CK) participated in discussions until a consensus was
reached, and the resultant decision was verified by the fourth
author (MC).
Data Extraction
Two authors (MK and EK) independently extracted the data
elements from the studies included in the final analysis. The
data sheet contained fields for first author, year of publication,
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country, participants, indication, sample size, age of participants,
study duration, intervention, comparator, follow-up assessment,
and outcomes. If some elements of the desired data were not
reported in a study, we contacted the corresponding author of
the study in an attempt to obtain these data. When a study
included multiple control arms, we utilized the control arm that
most closely matched the intervention, such as a group that
received advice regarding walking and a group that was
administered a light-resistance exercise program.
Quality Assessment
Two authors (MK and EK) independently assessed the risk of
bias in accordance with the Cochrane Collaboration’s risk of
bias tool, which focuses on seven domains: random sequence
generation, allocation concealment, blinding of participants and
personnel, blinding of outcome assessment, incomplete outcome
data, selective reporting, and other sources of bias (which were
scored as high, low, or unclear) [23]. In the case of
disagreement, a third person (CK) participated in the discussion
to resolve the disagreement. The results of the risk of bias
assessment were inputted into the software Review Manager
(RevMan) version 5.4 (The Cochrane Collaboration, 2020) to
visually represent the results.
Data Synthesis and Statistical Analysis
The meta-analysis was conducted to compare the standardized
mean difference in walking performance, functional status, and
QoL pre- and postintervention in patients who were randomly
allocated to mHealth intervention groups or control groups. We
analyzed continuous data by computing the mean and SD, and
the standardized mean differences (SMDs) of the outcome
variables were calculated using Hedges g, which was weighted
according to the sample sizes in the studies [24]. When an
original study did not provide SD values, we calculated them
using reported 95% CI, range, and sample size according to the
guidelines [24] and estimating formulae [24,25].
The SD values were calculated using the following formulae:
In the meta-analysis, the change-from-baseline value of the
outcome variables was used, and if there were no change values,
the postintervention values were used for analysis [24]. When
such data were not available from the original study, we
contacted the corresponding authors to request the relevant data.
In a few cases, the data remained unavailable, so we excluded
one study from the functional status analysis [26] and two
studies from the QoL analysis [26,27] in the meta-analysis.
We assessed heterogeneity using two methods. First, we
qualitatively performed a clinical judgment of differences in
study populations and the follow-up durations of each study.
Second, we performed a quantitative assessment, determining
statistical heterogeneity using Cochrane Q (χ2 test) and I2
statistics after visual inspection of forest plots [24]. We
considered heterogeneity to be substantial if the I2 value was
greater than 75% or if the P value of the χ2 test was less than
0.1. We utilized a random-effects model to calculate the effect
size when the included studies were heterogeneous [24]. We
used a fixed-effect model, as the number of studies included
was small, which presented a risk that the estimation of variance
between the studies would be inaccurate [28].
In the meta-analysis of walking performance, the outcomes
measured at baseline and at 12 weeks were used for analysis to
reduce the heterogeneity of the study periods. When an original
study did not measure outcomes at 12 weeks, we did not include
it in the pooled analysis [29]. Four of the five studies used
change-from-baseline values [26,27,30,31], and one study used
postintervention values because the mean change could not be
calculated [32] according to the Cochrane handbook for
systematic reviews of interventions [24]. Pain-free walking was
measured based on claudication onset time or claudication
distance, which was defined as the moment the patient wished
to stop walking as a result of claudication [26,27,30,31].
Maximal walking was measured using peak walking time or
maximum walking distance, which was defined as the moment
the patient was forced to stop walking as a result of reaching
maximal claudication level [26,27,30,31]. The 6-minute walk
test (6MWT) was used to measure the distance that the
participants walked in the hallway for 6 minutes [29,32].
Sensitivity analysis was conducted to assess the influence of
one single study being removed on the overall effect size. We
did not use funnel plots for assessing publication bias, as the
number of studies included was less than 10 [33]. Where
statistical pooling was not appropriate, the findings were
synthesized narratively. All analyses were conducted using
RStudio (version 1.3.1056; RStudio, PBC).
Results
Study Selection
Figure 1 shows our search process and the results obtained
through our search strategy in a PRISMA flow chart.
We identified a total of 1488 articles from the search of seven
databases. After we eliminated duplicates, 1207 articles
remained. Of these remaining articles, a further 1171 were
excluded based on screening of their titles and abstracts. Two
were included after manual searches, and an additional 31 were
excluded after full-text readings. Finally, seven studies met the
inclusion criteria and were included in the review, and six of
them were included in the meta-analysis. One study was
excluded from the meta-analysis because it applied mHealth
strategies to the SET group, in contrast to the other studies,
which applied mHealth strategies to the HBET group; including
this study would have resulted in difficulties merging the effect
sizes [34].
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Figure 1. PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) flow chart of the study selection process. mHealth: mobile
health; PAD: peripheral artery disease; RCT: randomized controlled trial.
Study Characteristics
The characteristics of the seven included studies are presented
in Table 1.
One study was a pilot RCT [31], and the other studies were
RCTs [26,27,29,30,32,34]. Of the studies, five were undertaken
in the United States [26,27,29,30,32], one in the United
Kingdom [31], and one in the Netherlands [34]. All participants
were diagnosed with PAD; five studies included patients with
symptomatic PAD [26,27,30,31,34], one study included patients
with symptomatic or asymptomatic PAD [29], and one study
included patients with asymptomatic PAD [32]. The number of
participants varied from 19 to 300, and the mean age of the
participants was over 65 years. Of the studies, six applied
mHealth strategies in HBET [26,27,29-32] and one study applied
mHealth strategies in SET [34]. Regarding the total duration of
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the studies, four studies were performed for 12 weeks
[26,27,30,32], one study was performed for 36 weeks [29], and
two studies were performed for 48 weeks [31,34].
Table 1. Characteristics of the included studies (N=7).
Study dura-
tion (weeks)
Age of participants (years), mean
(SD)
Sample size (n)Indication of participantsCountryStudy
48mHealth-based SET group: 65.6
(10.5); SET group: 66.1 (9.0); con-
trol group: 66.9 (8.6)
mHealtha-based SETb group: 90;
SET group: 109; control group: 101
Fontaine stage IINetherlands[34]
4869.1 (10.4)mHealth-based HBETc group: 20;
control group: 17
Intermittent calf claudicationUnited Kingdom[31]
1269.4 (8.4)mHealth-based HBET group: 10;
control group: 9
Exercise limited by claudica-
tion and resting ankle brachial
index <0.90
United States[30]
1265 (9)mHealth-based HBET group: 60;
SET group: 60; light-resistance ex-
ercise program group: 60
Symptomatic PADdUnited States[26]
12mHealth-based HBET group: 65
(11); SET group: 66 (12); control
group: 65 (10)
mHealth-based HBET group: 40;
SET group: 40; control group: 39
Intermittent claudicationUnited States[27]
36mHealth-based HBET group: 70.1
(10.6); control group: 70.4 (10.1)
mHealth-based HBET group: 97;
control group: 101
Regardless of symptoms, ankle
brachial index <0.9
United States[29]
12mHealth-based HBET group: 68
(7.5); control group: 68 (10.6)
mHealth-based HBET group: 19;
control group: 19
Asymptomatic PAD and resting
ankle brachial index <0.9
United States[32]
amHealth: mobile health.
bSET: supervised exercise therapy.
cHBET: home-based exercise therapy.
dPAD: peripheral artery disease.
Characteristics of Study Outcomes
All studies included comparators, and they are presented with
the intervention methods and outcomes in Table 2.
One study did not administer any intervention to the comparators
[29]; four studies provided advice on walking exercises,
brochures, a book, or a related video series [27,30,32,34]; one
study provided a light-resistance exercise program [26]; and
one study did not report any intervention [31]. In all studies,
the outcome variables were measured through objective
indicators (walking performance), and the subjective indicators
of functional status and QoL were measured in five studies
[26,27,29,31,34]. Walking performance was measured through
a treadmill test or 6MWT at baseline and at the end of the study
or at certain time points during the study. In six studies, the
results of the walking performance tests showed that the
mHealth group significantly improved [26,27,30-32,34].
Functional status was measured using a PAD-specific measure
of the self-report Walking Impairment Questionnaire (WIQ).
Four studies measured QoL using the 36-Item Short Form Health
Survey (SF-36) [26,27,29,34], while one study used the Vascular
Quality of Life Questionnaire (VascuQoL) [31]. Four studies
showed a significant improvement of functional status and QoL
in the mHealth group [26,27,31,34], one study showed no effect
[29], and two studies did not measure functional status or QoL
[30,32].
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ACDa, FCDb: increased significantly in all groups (P<.01);
WIQc: total score improved in the SETd group (P=.004);
SF-36e: total score improved in the SET group (P<.001)





Referred to a local physical ther-
apist; provided feedback using
wearable activity tracker records
[34]
MWDf: increased significantly in mHealthg group (P=.001);
CDh: significantly improved in mHealth group (P=.005);
VascuQoLi: significantly improved in mHealth group
(P=.004)
Baseline, and 3, 6,
and 12 months
Not reportedDaily activity goals setting using
wearable activity monitor; provid-
ed feedback using wearable activ-
ity tracker records at each fol-
low-up visit
[31]
COTk, PWTl: increased significantly in mHealth group
(P<.06); moderate-high activity minutes: increased signifi-




copy of the PAD
book
Provided monthly feedback using
wearable activity tracker records;
electronic PADj book; weekly
emails containing PAD tip;
counseling and exercise prescrip-
tions over the telephone
[30]
COT, PWT, 6MWTm: increased significantly in mHealth
group (P<.001); WIQ: increased significantly in mHealth
group (P<.05); SF-36: increased significantly in mHealth
group (P=.01)






new instructions) and motivation
using wearable activity tracker
records and logbook
[26]
COT, PWT: increased significantly in mHealth group
(P<.001); WIQ: increased significantly in mHealth group
(P<.05); SF-36: increased significantly in mHealth group
(P<.01)
Baseline, and 1, 2, 4,





new instructions) and motivation
using wearable activity tracker
records and logbook
[27]






Provided coaching on exercise
goals using wearable activity
tracker records over the tele-
phone; group telephone calls to
share their successes and chal-
lenge experiences (2 calls/month)
[29]










aACD: absolute claudication distance.
bFCD: functional claudication distance.
cWIQ: Walking Impairment Questionnaire.
dSET: supervised exercise therapy.
eSF-36: 36-Item Short Form Health Survey.
fMWD: maximum walking distance.
gmHealth: mobile health.
hCD: claudication distance.
iVascuQoL: Vascular Quality of Life Questionnaire.
jPAD: peripheral artery disease.
kCOT: claudication onset time.
lPWT: peak walking time.
m6MWT: 6-minute walk test.
Intervention Adherence and mHealth Functions
Table 3 summarizes the attrition and adherence rates, type of
mHealth devices used, and applied mHealth functions.
The attrition rate in the mHealth groups ranged from 0% to
28%, and an adherence rate was reported in only two studies
(exceeding 80% in both cases) [26,27]. Regarding the use of
wearable activity trackers, in five studies the participants wore
the trackers on their wrists [26,27,30,31,34], and in other studies
they wore them on the ankles [29] or anterior thigh and waist
[32]. The common functions applied to mHealth interventions
were recording and display. In addition, the reminding/alerting
function [31], guiding function [29], and communication
function [32] were used.
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Table 3. Summary of attrition and adherence rates, mobile health (mHealth) devices used, and applied mHealth functions.
mHealth functionsmHealth devices usedAdherence rateAttrition rateStudy
Recording, displayPersonal Activity Monitor accelerometer
(PAM BV)
Not reportedmHealth-based SETa group: 16%; SET group:




Nike+ FuelBand (Nike, Inc)Not reportedmHealth-based HBETb group: 20%; control
group: 24%
[31]
Recording, displayFitbit Charge device (Fitbit, Inc)Not reportedmHealth-based HBET group: 0%; control group:
11%
[30]
Recording, displayStepWatch3 (Orthoinnovations, Inc)mHealth-based
HBET group: 81%;
SET group: 82%
mHealth-based HBET group: 12%; SET group:
13%; control group: 15%
[26]
Recording, displayStepWatch3 (Cyma Inc)mHealth-based
HBET group: 83%;
SET group: 85%
mHealth-based HBET group: 28%; SET group:










Gruve activity tracker (Gruve Solutions;
Muve Inc); activPAL (PAL Technologies
Ltd); online dashboard
Not reportedNo patients withdrew during the study period[32]
aSET: supervised exercise therapy.
bHBET: home-based exercise therapy.
Quality Assessment of Literature
The risk of bias analysis is shown in Figure 2 (individual studies)
and Figure 3 (summary graph). All of the studies were assessed
to have a low risk of selection bias. Due to maintaining the
blinding of investigators and participants in exercise
interventions, six of the seven studies were assessed to have a
high risk of performance bias [26,27,30-32,34]. However, both
attrition bias and reporting bias were generally assessed as low
risk. With the exception of studies that reported that assessors
were not blinded due to resource constraints [30,31], detection
bias was assessed as unclear [26,27,32] or low risk [29,34].
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Figure 2. Risk of bias: individual studies.
Figure 3. Risk of bias: summary graph.
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Meta-Analysis Findings: Effects of mHealth Exercise
Interventions
Walking Performance
All six studies included in the meta-analysis reported walking
performance. A treadmill test [26,27,30,31] and 6MWT
[26,29,32] were used. The mHealth intervention groups showed
an overall improvement in pain-free walking (SMD: 0.51, 95%
CI 0.13-0.88; P=.008), maximal walking (SMD: 0.45, 95% CI
0.03-0.87; P=.04), and 6MWT distance (SMD: 0.92, 95% CI
0.59-1.24; P<.001) when compared with the control groups
(Figure 4).
There was heterogeneity when pooling the pain-free walking
(χ2=5.58, P=.13; I2=46%), maximal walking (χ2=6.9, P=.08;
I2=56%), and 6MWT (χ2=0.27, P=.60; I2=0%) results. There
was no significant difference found from omitting one single
study using sensitivity analysis (Multimedia Appendix 3).
Figure 4. Forest plot of walking performance (up to the 12-week point). 6MWT: 6-minute walk test; mHealth: mobile health; SMD: standardized mean
difference.
Functional Status
Reported functional status, two of which were included in our
quantitative synthesis [27,29] (Figure 5).
The two included studies showed that the mHealth intervention
groups significantly improved their WIQ distance (SMD: 0.25,
95% CI 0.02-0.49; P=.04) [27,29]. Other elements such as
walking speed and stair-climbing ability did not show
statistically significant improvements.
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Figure 5. Forest plot of functional status. mHealth: mobile health; SMD: standardized mean difference; WIQ: Walking Impairment Questionnaire.
QoL
Four studies reported QoL, two [29,31] of which were included
in the meta-analysis (Figure 6).
The two studies included in the meta-analysis measured QoL
using VascuQoL [31] and SF-36 [29], respectively. The results
showed that the mHealth intervention groups did not show
significant improvements in QoL compared with the control
groups (P=.48) but showed significant heterogeneity (χ2=37.3,
P<.01; I2=97%).
Figure 6. Forest plot of quality of life. mHealth: mobile health; SMD: standardized mean difference.
Discussion
Principal Findings
In patients with PAD, effective and structured HBET can be a
more accessible and acceptable alternative to SET in terms of
burden and cost [3,8]. Therefore, this study is meaningful as
the first meta-analysis of the effectiveness of applying mHealth
as a strategy to provide structured exercise interventions at home
for patients with PAD. In mHealth-based HBET, adherence is
important for increasing the beneficial effects of exercise [8].
However, only two studies reported adherence rates [26,27].
This reflects the fact that while adherence in exercise
intervention is a precursor and an important predictor for
improvement of outcome, it is not always measured [35,36].
The adherence rates in the two above-mentioned studies both
exceeded 80%. This is similar to the adherence rates reported
in systematic reviews of exercise programs for older adults
(65% to 86%) [37], RCTs featuring exercise referral schemes
(pooled mean: 80%) [38], and exercise groups for patients with
PAD (78%) [7]. Although maintaining high adherence rates is
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difficult in HBET [3], HBET using mHealth technologies such
as wearable activity tracking devices seems to maintain high
adherence. Future studies should report adherence rates; further,
among the various measures of adherence [35,37,38], an
appropriate and accurate measure for adherence rates for patients
with PAD should be identified and applied.
A total of seven studies were included in our systematic review,
and six studies were included in the meta-analysis. The studies
included in the meta-analysis all applied mHealth techniques
in HBET. During the 12-week interventions, the mHealth group
showed significant improvements in pain-free walking, maximal
walking, and 6MWT distance when compared with the control
group. In one study that was not included in the pooled analysis
of walking performance [29], the intervention was performed
for 9 months and showed no effects on 6MWT distance in the
mHealth group.
The functional status of the patients was measured using the
WIQ, which has been validated as a measure of perceived
difficulty concerning walking distances and speeds and the
ability to climb stairs [39]; significant improvements were seen
in walking distance but benefits regarding walking speed and
stair-climbing ability were not observed. These results are
similar to those of other exercise intervention studies, which
reported significant effects on WIQ walking distance and no
effects on other outcome measures [40,41].
The mHealth group did not show a significantly improved QoL.
In other studies, the effect of mHealth-based interventions on
QoL was unclear. Some meta-analyses have reported that
mHealth-based interventions did not improve QoL in cancer
survivors [42,43], while another study reported improved QoL
in patients with coronary heart disease [44]. Therefore, the
long-term effect of mHealth interventions on QoL should be
investigated further.
Limitations
A major limitation of this study was that the type of mHealth
devices used in the reviewed studies was restricted to wearable
activity trackers. It is important to monitor activity to promote
physical activity in patients with PAD [31]; however, activity
trackers may not have a sufficient impact in relation to inducing
changes in health behaviors and improving adherence, as they
provide a limited range of mHealth functions. Future studies
need to investigate the effects of providing patients with PAD
with a wider range of mHealth functions such as real-time advice
and symptom monitoring [13,14,45], feedback and verification
of achievement of individually set goals [6,13,14], and coaching
chatbots [46]. In addition, this study was not able to review
studies evaluating walking performance beyond 12 weeks, which
was a result of the limited durations of the studies. Since all of
the studies were based on structured exercise programs with
recommended durations of at least 12 weeks [3], there were
limited findings for long-term effects. PAD is a chronic disease
for which treatment should involve sustained walking exercise;
thus, it is important that interventions have effects on the
long-term performance of walking exercises [3]. In future
studies, the effects of long-term mHealth-based exercise
interventions will need to be identified.
Conclusions
This study provides evidence that mHealth-based exercise
interventions applied through HBET for patients with PAD
improve pain-free walking, maximal walking, 6MWT distance,
and walking distance as elements of functional status. In
addition, an HBET group that received the mHealth intervention
showed an adherence rate similar to the SET group. We found
that using mHealth as part of exercise interventions is an
important strategy to improve the walking ability and exercise
adherence rate of patients with PAD at home or in the
community in their daily living environments. Future studies
should consider the use of various and suitable functions of
mHealth to improve the adherence rate and the effectiveness of
exercise interventions.
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